Effects of Lipomyces starkeyi KSM 22 Glucanhydrolase on human gingival fibroblasts.
10.5051/jkape.2002.32.3.665
- Author:
Hyun Jeong YUN
1
;
Hyun Ju CHUNG
;
Ok Su KIM
;
Do Man KIM
Author Information
1. Department of Periodontology, College of Dentistry and Dental Science Research Institute, Gwangju, Korea.
- Publication Type:Clinical Trial ; In Vitro ; Original Article
- Keywords:
Lipomyces starkeyi KSM 22 glucanhydrolase;
chlorhexidine;
human gingival fibroblasts;
cytotoxic
- MeSH:
Amylases;
Anti-Bacterial Agents;
Cell Count;
Cell Proliferation;
Chlorhexidine;
Dental Plaque;
Dextranase;
Fibroblasts*;
Gingivitis;
Humans*;
Hydrolysis;
Inflammation;
Lipomyces*;
Streptococcus mutans
- From:The Journal of the Korean Academy of Periodontology
2002;32(3):665-683
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
A novel glucanhydrolase from a mutant of Lipomyces starkeyi KSM 22 has additional amylase activity besides mutanolytic activity and has been suggested as promising anti-plaque agent. It has been shown effective in hydrolysis of mutan, reduction of mutan formation by Streptococcus mutans and removal pre-formed sucrosedependent adherent microbial film and has been strongly bound to hydroxyapatitie. These in vitro properties of Lipomyces starkeyi KSM 22 glucanhydrolase are desirable for its application as a dental plaque control agent. In human experimental gingivitis model and 6 month clinical trial, mouthrinsing with Lipomyces starkeyi KSM 22 dextranase was comparable to 0.12% chlorhexidine mouthwash in inhibition of plaque accumulation and gingival inflammation and local side effect was negligible. This study was aimed to evaluate the cytotoxic effect of Lipomyces starkeyi KSM 22 glucanhydrolase on human gingival fibroblasts. Primary culture of human gingival fibroblasts at the 4th to 6th passages were used. Glucanhydrolase solution was made from lyophilized glucanhydrolase powder from a mutant of Lipomyces starkeyi KSM 22 solved in PBS and added to DMEM medium to the final concentration of 0.5, 1, and 2 unit. Cells were exposed to glucanhydrolase solution or 0.1 % chlorhexidine and the cells cultured in DMEM with 10% FBS and 1% antibiotics as control. After exposure, the morphological change, cell attachment, and cell activity by MTT assay were evaluated in 0.5, 1.5, 3, 6, 24 hours after treatment. The cell proliferation and cell activity was also evaluated at 2 and 7 days after 1 minute exposure, twice a day. The cell morphology was similar between the Lipomyces starkeyi KSM 22 glucanhydrolase groups and control group during the incubation periods, while most fibroblasts remained as round cell regardless of incubation time in the chlorhexidine group. The numbers of the attached cells in the glucanhydrolase groups were comparable to that of control and significantly higher than the chlorhexidine group. The numbers of the proliferated cells in the glucanhydrolase groups at 7 days of incubation were comparable to the control group and higher than the chlorhexidine group. The cell activity in glucanhydrolase groups paralleled with the increased cell number by attachment and proliferation. According to these results, Lipomyces starkeyi KSM 22 glucanhydrolase has little harmful effect on attach-ment and proliferation of human gingival fibroblasts, in contrast to 0.1% chlorhexidine which was cytotoxic to human gingival fibroblasts. Therefore this glucanhydrolase preparation is considered as a safe and promising agent for new mouthwash formula in the near future.
